As the North American cannabis industry continues its accelerated growth, billion-dollar investments and go public transactions earn headlines. Yet much less information is available regarding private market activities – including seed funding rounds, late stage financing, and M&A deals – that play a central role in defining the trajectory of this emerging sector. Leaving the cannabis entrepreneurs, operators and investors building this industry in the dark.
In an effort to provide frictionless access to reliable and accurate market data, we are proud to release the Cannabis Private Investment Review. Powered by data from Pitchbook, the premier data provider for the private and public equity markets, the Review examines this generation’s most dynamic industry from a private market perspective, investigating venture capital and private equity trends, and the consolidating M&A deals reshaping the cannabis landscape.
Key Insights from the Report
- $1.3 billion in venture capital investments YTD already exceeds 2018
- Why US private equity activity outpaces Canada’s legal market
- Average valuations for seed and late-stage financings continue to rise
- Adult-Use vs Medicinal: Which has better long-term projections?